Effect of long term azithromycin on exacerbations in non CF bronchiectasis

M. Naeem, K. Nourain, R. Reddy (Kettering, United Kingdom)

Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Session: Antibiotics, antifungals and other therapeutic options
Session type: Poster Discussion
Number: 4695
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Naeem, K. Nourain, R. Reddy (Kettering, United Kingdom). Effect of long term azithromycin on exacerbations in non CF bronchiectasis. Eur Respir J 2014; 44: Suppl. 58, 4695

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014

COPD and pseudomonas aeruginosa, an association
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014

Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Exacerbations in non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

IPF exacerbations: Role of Respiratory tract infections
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018


Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Vitamin D levels in patients with non-CF bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015



Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Bacterial and viral microbiomes in COPD exacerbations of unidentified cause
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014